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Total RNA was purified from human fetal calvaria and articular cartilage. Messenger RNAs for type I 
and II collagens were identified by hybridization using cDNA clones for chicken proal(I proa2(1)- and 
proal(II)collagen mRNAs and by analysis of cell-free translation products of these RNAs by polyacryl- 
amide gel electrophoresis. The size of human proal(II)collagen mRNA is approx. 5100 bases. Translatability 
of cartilage specific type II collagen mRNA was found to be concentration dependent: with increasing total 
RNA concentrations the relative translation of type II collagen mRNA was reduced with respect to type 
I mRNAs. 
Collagen Human type II collagen Cartilage Hybridization mRNA Cell-free translation 
1. INTRODUCTION 
Type II collagen forms about one half of the 
organic matrix of articular cartilage. In addition to 
maintaining tissue strength and flexibility, carti- 
lage specific type II collagen plays an important 
role during embryonic development of cartilage 
and bone [ 11. At least 9 different collagen types are 
now known. Types I and II are the major collagens 
expressed during cartilage differentiation. Type I 
collagen consists of two identical a l(I)-chains and 
one a2(1)-chain and type II collagen of 3 cul(II)- 
chains. The different chains are products of 
different genes: the corresponding mRNAs are 
translated into (pre)procu-chains which undergo ex- 
tensive post-translational modification including 
association of three procu-chains into triple helix 
before secretion into extracellular matrix [2]. 
Messenger RNA for chicken type II collagen has 
been identified [3] and used for the construction of 
the corresponding cDNA clones [4,5] with subse- 
quent identification of the chicken [6] and human 
[7] genes for type II collagen. This tudy was 
Abbreviation: cDNA, complementary DNA 
undertaken to characterize the mRNA for human 
type II collagen. Alterations in the structure and 
expression of this collagen type are of special in- 
terest in studies on human anticular diseases. 
2. MATERIALS AND METHODS 
Total RNA was purified from calvaria and 
articular cartilage of human fetuses obtained at 
therapeutic abortions and from calvaria and sterna 
of 17-day-old chick embryos as in [8]. 
For hybridizations total RNAs were denatured 
with glyoxal and dimethyl sulfoxide and electro- 
phoresed in 0.75% agarose gels [9]. After the frac- 
tionation one part of the gel was stained with 
ethidium bromide; RNA from the other part&was 
transferred by blotting to nitrocellulose [lo]. The 
filters were hybridized with plasmid DNAs nick- 
translated using t3*P] dCTP (> 3000 Ci/mmol, 
Amersham International, England) and a commer- 
cial reagent kit (BRL, Gaithersburg, MD). The fol- 
lowing plasmids were used as probes: pCAL1 and 
pCAL2 containing sequences complementary to 
chicken procu 1 (I)- and procu2(I)collagen mRNAs 
[ 111, and pCAR1 containing cDNA for chicken 
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pr~l(II~ollagen mRNA [4,6]. The filters were 
washed at 50°C as [lo] and exposed with Kodak X- 
omat film using intensifying screens. 
Messenger RNAs in the total RNA preparations 
were translated in a rabbit reticulocyte lysate sys- 
tem with [35S]methionine (approx. 1400 Ci/mmol) 
as the radioactive precursor (both from Amersham 
International). The incubations were performed as 
suggested by the supplier using different RNA con- 
centrations. Electrophoretic fractionation of the 
translation products was performed in 5-l 1% 
polyacryl~ide gradient gels 1121 followed by 
~uorographic analysis [ 131. Where indicated, ali- 
quots of the translation reactions were incubated 
prior to electrophoresis with purified bacterial 
collagenase (form III, Advance Biofactures, 
Lynbrook, NY) as in [3]. 
3. RESULTS AND DISCUSSION 
The presence of type II collagen mRNA in total 
RNA preparations from human fetal cartilage was 
28s rRNA- 
18s rRNA- 
shown by nucleic acid hybridization using cloned 
cDNAs for chicken type I and II collagen mRNAs 
as probes. RNA from calvaria was chosen for 
reference as this tissue actively produces type I col- 
lagen but does not contain any type II collagen 
mRNA [3]. Nick-translated plasmid pCAR1 hybri- 
dized strongly to mRNA bands in chicken and 
human cartilage (fig.1). We showed previously 
that the major mRNA for chicken procwl(II)col- 
lagen was 5300 bases long (with variable amounts 
of a larger mRNA species of 7000 bases) [4]. The 
larger band is not detectable in fig. 1 (lane Bl). The 
probe also hybridized strongly to an mRNA of 
about 5100 bases in human cartilage RNA (lane 
B2) and slightly to two mRNAs in human calvaria 
(lane B3). As these two bands were also recognized 
by pCAL1 (lane C3) and cell-free translation of 
this RNA did not produce any preprml(II)- 
chains, the hybridization is most likely due to 
cross-hybridization between pCAR1 and human 
proa!l(I)collagen mRNAs and not to the presence 
of type II collagen mRNA in human calvaria. The 
Fig. 1. Analysis of RNAs from calvaria nd cartilage by hyb~di~tion with cDNA probes. The RNA samples (lO-2Opg 
each) were electrophoresed in 0.75% agarose gels: (1) chicken cartilage, (2) human cartilage, (3) human calvaria nd 
(4) chicken calvaria. (A) Ethidium bromide staining of the gel with human rRNAs marked. (3) Hybridization pattern 
obtained with plasmid pCAR1. (C) Hybridization pattern with pCAL1. For clarity the two mRNAs for chicken 
pro(y l(I)collagen are marked to the right as the RNA is somewhat degraded. 
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analysis of the published cDNA sequences covered 
by probes pCAL1 and pCAR1 shows an 86.2% 
homology between chick and human u 1 (I)-mRNAs 
whereas chick (Y l(II)- and human a l(I)-mRNAs 
share a homology of 76.0%. The mRNA for 
human procu2(I)collagen shows considerably less 
homology with pCAL1 (65.6%) and pCAR1 
(68.2%) [14-161. No specific hybridization of 
pCAR1 was seen to chick calvaria RNA (lane B4). 
Fig.lC shows hybridization of pCAL1 to an 
identical nitrocellulose filter. The probe hybridized 
to two mRNA bands in chicken (lane C4) and 
human (lane C3) calvaria as reported [ 11,171, but 
also slightly to two mRNA bands in human car- 
calvaria cartilage 
a b c d e abcde0 
Fig.2. 
al(l) - 
al(ll)- 
a2(1)- 
:I14 reet :ranslation 
10. (W 25, (c) 50, 
of human cartilage and calvaria RNAs. The different RNA concentr 
(d) 100, (e) 150ng/& (0) No RNA added. Marked in the figure are 
type I and II collagens. 
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tilage RNA (lane C2). Some type I collagen mRNA 
is present in our human cartilage RNA (fig.;?), but 
part of the hybridization observed may be due to 
cross-hybridization of the type I and II sequences 
even under the stringent washing conditions used. 
Similarly, plasmid pCAL2 hybridized to two 
mRNAs in human calvaria RNAs and weakly to 
the corresponding mRNA in human calvaria (not 
shown). Recently the homology between chicken 
and human type II collagen mRNAs was utilized to 
isolate a genomic clone for human type II collagen 
using pCAR1 as the probe [7]. 
Electrophoretic fractionation of the cell-free 
translation products directed by human calvaria 
mRNAs revealed two major bands (fig.2) which 
were sensitive to bacterial collagenase (fig.3). 
These must correspond to the preprwl(I)- and 
prepro&(I)-chains as type I collagen is the major 
protein produced by calvaria [3]. The bands 
migrated very close to the chick preprm-chains 
(not shown). A similar analysis of cartilage 
mRNAs revealed 3 ~ollagenase-sensitive transla- 
tion products two of which comigrated with the 
chains of type I collagen (fig.2,3). This strongly 
suggests that the third band corresponds to the car- 
tilage specific preprocvl(II)-chain. Further evi- 
dence for this is provided by the fact that the band 
comigrated with chick preprwl(II)-chain (not 
shown). Cell-free translation of the RNAs from 
cartilage at different concentrations revealed that 
the translatability of the procvl(II)collagen mRNA 
was inhibited at high RNA concentrations with 
reference to type I collagen (fig.2). A similar in- 
hibition has also been observed in cell-free transla- 
tion of type III collagen at high RNA concentra- 
tions [18]. 
calvaria 
a b 
cartilage 
a b 
Fig.3. Identification of collagenous translation products 
by sensitivity to bacterial collagenase. Human cartilage 
and calvaria RNA (25 ng/pl) was translated in a reticulo- 
cyte lysate system and electrophoresed before (a) and 
after (b) digestion with bacterial collagenase. The pre- 
procu-chains of type I and II collagens are marked in the 
figure. 
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The mRNA for human procv l(II)colIagen identi- 
fied in RNA isolated from cartilage should prove 
to be useful in studies on identification and expres- 
sion of human type II collagen genes. 
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